echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Yangtze River's exclusive review injection meets its rivals! 13 pharmaceutical companies including Shisiyao speed up food rush

    Yangtze River's exclusive review injection meets its rivals! 13 pharmaceutical companies including Shisiyao speed up food rush

    • Last Update: 2020-06-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit

    Pharmaceutical Network June 10, recently, Shijiazhuang four drugs hydrochloric acid right Metomidin injection 3 class imitation listing application to be accepted by CDE, if approved according to the new classification is considered the same evaluation, the product has been evaluated only Yangzijiang 1 enterprise, in the first round of national band procurement, Yangzijiang exclusive winning bid "4 plus 7" and the alliance region, sales in 2019 surge 181 times!Figure 1: Shijiazhuang four drugs of hydrochloric acid right Metomidin injection declarationSource: CDE official website
    Figure 2: Hydrochloric acid right Metomi ding injection TOP3 enterprise market shareSource: Minnet China public medical institutions terminal competition pattern
    salt Acid right metomidin injection is a heavy-duty variety of psychostable drugs, minet data show that in 2019 in China's urban publichospitals, county-level public hospitals, urban community centers and township hospitals (referred to as China's public medical institutions) terminal sales of nearly 3.6 billion yuanIn June 2018, Yangzijiang's hydrochloric acid right-metomidin injection 3 class imitation listing application was approved for production, and treated as a review, and then the exclusive winning bid "4 plus 7" collection, alliance area collection, TOP3enterprisesmarket share was greatly shuffledIn 2019, the market share of the leading company Hengrui fell sharply to 53.21%, Enwar declined to TOP3 but the market share was reduced to 6.46%, and top2 enterprises from the top of the Yangzi River, with sales of 1.186 billion yuan, a growth rate of 1814.75%Table 1: The 3 types of imitation and consistency evaluation of the right metomiat injection of hydrochloric acid right-hand tomic injections in the reviewsource: MED China Drug Review Database 2.0
    as of now, in addition to Shijiazhuang four drugs received CDE acceptance, there are Nanjing Zhengda Tianqing Pharmaceutical s5 types of generic listing applications in the review approval, in addition, Hengrui, Enhua and other 7 consistent evaluation applications are also in the review
    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.